This page features general updates about prostate cancer, research and studies, hot topics, news articles and editorials. You also might be interested in ZERO’s Blog, which features inspiring stories, commentary, and insight into news and current events from contributors throughout the prostate cancer community.
Metastatic prostate cancer on the rise since decrease in cancer screenin...
A new study from Keck Medicine of USC finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against routine prostate cancer screenings. The introduction of screenings ...
FDA Approves Pluvicto for Progressive, PSMA-Positive Metastatic CRPC
The FDA has approved lutetium Lu 177 vipivotide tetraxetan for the treatment of adult patients with prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer who have previously received other anticancer therapies ...
Delaware is shrinking racial gaps in cancer death. Its secret? Patient n...
Delaware's progress against cancer inequities has been slow and steady, and not without its challenges. The state's overall cancer death rate has gradually fallen from the second-highest among states in the 1990s to the 15th ...
ZERO featured in “One Hour Cares” charity contest
HAMPTON ROADS, Va. - ZERO is the leading national nonprofit with the mission to end prostate cancer through advancing research, improving the lives of men and their families, and inspiring action. We talk with Regional ...
Al Roker walks the runway to support ZERO’s Blue Jacket Fashion Sh...
TODAY’s Al Roker walked the runway at the Blue Jacket Fashion Show on Thursday. Roker strutted the catwalk for a good cause, with donations from the event going to prostate cancer education and research. Roker ...
Andre Leon Talley honored at ZERO’s Blue Jacket Show
Vogue’s first and only black creative director, André Leon Talley, will be honored at New York Fashion Week on Thursday, Page Six has exclusively learned. Designer Frederick Anderson will pay tribute to Talley, who died ...
Treatment with abiraterone significantly improves survival in advanced p...
In December, researchers reported findings from a study showing that the drug abiraterone halves the risk of prostate cancer death among a specific group of patients who previously would not have been treated with it. Currently, ...
August 2016
- Daily Swims for a 90-Year-Old (WSJ)
- Henry Schein Joins IMF and LUGPA to Raise Awareness of Prostate Cancer and the Importance of Early Detection (PR Newswire)
- National Football League Alumni Association and Cancer Treatment Centers of America® Team Up for “Prostate Pep Talk” (Charleston Chronicle)
- Active Surveillance? Watchful Waiting? What Every Man With Prostate Cancer Should Know (Cancer.net)
- Pfizer Buying Maker of Prostate Cancer Drug Xtandi for $14B (Philly.com)
- Researcher Explores Biologic Basis for Disparities in Prostate Cancer Outcomes (OncLive)
- Continuing Docetaxel Therapy May Improve Survival in Prostate Cancer (Cancer Therapy Advisor)
- GPS for the Prostate Can Detect Cancer Earlier (11 Alive)
- Role of Vitamin D Receptor Gene Cdx2 and Apa1 Polymorphisms in Prostate Cancer susceptibility: a Meta-Analysis (BioMed Central)
- Cardiff University Receive Grant for ‘Pioneering’ Prostate Cancer Research (ITV)
- Accurate Risk Status Assessment Critical to Prostate Cancer Care (OncLive)
- Psychological Effects From ADT a Growing Challenge in Prostate Cancer (OncLive)
- Baltimore Breweries Aim to Raise Prostate Cancer Awareness with New Caps (Baltimore Sun)
- John McLaughlin, Provocateur of Public Affairs TV, Dies at 89 (The Washington Post)
- Alabama Woman to Receive National Certification to Train Cancer-Sniffing Dogs (AL.com)
- Sociodemographic Factors Impact Prostate Cancer Treatment Initiation (Cancer Therapy Advisor)
- Early Prostate Cancer Diagnoses Continue to Fall in U.S.: Study (US News Health)
- Incidence of Early Stage Prostate Cancer Lower After USPSTF Recommendation Against PSA Testing (Oncology Nurse Advisor)
- Integrating Diet and Exercise into Care of Prostate Cancer Patients on Androgen Deprivation Therapy (DovePress)
- New Treatment Target Found for Prostate Cancer Tumors (Speciality Pharmacy Times)
- Radiotherapy, Prostatectomy Confer Similar Outcomes for Aggressive Prostate Cancer (Healio)
- Online Programs Help to Address Effects of Prostate Cancer Treatment (OncLive)
- Quality of Life Similar For Men on Active Surveillance For Prostate Cancer vs Negative Biopsy (Medical Research)
- Custirsen Fails to Extend OS in Metastatic Castrate-Resistant Prostate Cancer (Healio)
- Men with Very High-Risk Prostate Cancer Live Longer with Radical Treatment (Prostate Cancer News Today)
- High-Grade Prostate Cancer Linked to Diabetes Drugs (Renal & Urology News)
- Researchers Pinpoint Key Regulatory Role of Noncoding Genes in Prostate Cancer Development (Medical XPress)
- Selenium May Cut Aggressive Prostate Cancer Risk (Renal & Urology News)
- Does a Prostate Cancer Therapy Up Alzheimer’s Risk? (Medscape)
- Compound Shows Promise as Next-Generation Prostate Cancer Therapy (Science Daily)
- A Tool to Aid Treatment Decisions in Prostate Cancer (AJMC)
- Computational Analysis of Prostate Cancer Networks Points Way to Patient-Specific Therapies (Prostate Cancer News Today)
- Grant to Support Research of Deadliest Form of Prostate Cancer (UF Health)
- Reserve ADT for African-American Men With High-Risk Prostate Cancer? (Cancer Network)
- One Year On: Inside Bayer’s Effort to Get Prostate Cancer Victims to Speak Up (PR Week)
- Idaho Woman Paddles the Yukon For Her Dad (Jackson Hole News & Guide)
- Caring for US Veterans Helped Lead Iraqi Immigrant to Develop Prostate Cancer Advances (OncLive)
- Cycling joy for former head teacher Trevor (York Press)
- Hormone therapy for prostate cancer may pose a risk for black men (Washington Post)
- High-dose radiation therapy as effective as surgery for aggressive prostate cancer (UCLA Health)
- European prostate cancer treatment is changing – what are the opportunities for marketers? (PMLive)
- Erectile Dysfunction Drugs: No Effect on Prostate Cancer Risk (MedScape)
- CrossFit Carries Paramus Father Through Cancer Treatment (Paramus)
- Analysis of metastatic prostate cancers suggests treatment options (University of Santa Cruz)
- Radiation Equal to Surgery for Prostate Cancer (Newsmax)
July 2016
- Harnessing the Immune System to Fight Cancer (NY Times)
- Robotic, Open Prostate Cancer Surgery Offer Similar Early Results (Renal & Urology News)
- Scientists Find Cancer in Million-Year-Old Fossil (CNN)
- Controversy Over Marvel’s Prostate Cancer Variant Covers (Bleeding Cool)
- Prostate Cancer Breakthrough Could Lead to new Diagnostic Tests and Treatments (Science Daily)
- Robotic Surgery for Prostate Cancer May Offer No Benefits Over Regular Surgery (NY Times)
- Protein ZMYND8 Tied to Suppression of Prostate Cancer Tumor Metasis (Science Daily)
- Occupational Exposure to Solar Ultraviolet Radiation and the Risk of Prostate Cancer (Uro Today)
- Prostate Cancer Isn’t Colorblind (NY Times)
- Decision Support and Shared Decision Making Help Patients Choose Plan for Low-Risk Prostate Cancer (Oncology Nurse Advisor)
- Expert Details Progression of Immunotherapy Agents in Prostate Cancer (Targeted Oncology)
- Tokai Pharma Shutters Prostate Cancer Drug Trial Early, Shares Crumble (Xconomy)
- Exploring Apalutamide in Patients with High-Risk Prostate Cancer (Targed Oncology)
- Markers that Cause Toxic Radiotherapy Side-Effects in Prostate Cancer Identified (Targeted Oncology )
- Dreicer Addresses Key Questions With Radium-223 in mCRPC (Onc Live)
- Word salad: What’s for dessert? (Healio)
- Shocking rise in advanced prostate cancer cases indicates men not following recommended screening regimen (Northern California News)
- One of the Quiet Oncology Heroes (Cure Today)
- Erroneous Study Of Advanced Prostate Cancer Criticized By Experts (Science World Report)
- Advanced Prostate Cancer On The Rise, Screening At Age 50 Key To Early Detection (The Huffington Post)
- HIFU Prostate Cancer Treatment Continues to Revolutionize Standard of Care (Prostate Cancer News Today)
- New Study Finds Cases Of Advanced (Metastatic) Prostate Cancer Rise Significantly In Last Decade – Are Changes To PSA Screening Guidelines To Blame? (PR News Wire)
- New Tool Helps Patients With Prostate Cancer Decide if Watchful Waiting is Right (Cure Today)
- Expert Stresses Importance of PSA-Based Screening in Early-Stage Prostate Cancer (OncLive)
- Advanced Prostate Cancer Cases Soar (AARP)
- Era of Precision Oncology for Prostate Cancer ‘Is Upon Us’ (Cancer Therapy Advisor)
- ASCO issues new guideline on chronic pain management in adult cancer survivors (ECancer News)
- Patnaik Highlights Evolution Toward Immunotherapy in Prostate Cancer (OncLive)
- Sun Pharma first to provide oncology treatments in ready-to-administer bags (Prostate Cancer News Today)
- Breast Cancer and ovarian cancer genes can be passed on by men to their children (Mirror)
- ST AMPEDE Trial and Patients with non-Metastatic Prostate Cancer (The Lancet)
- MCRPC: No Survival Benefit With Cabozantinib (MedPage Today)
- 225 Women Paddle for Prostate Cancer (CI News Today)
- Robot-Assisted Prostate Surgery Safe, Effective Long Term (Renal & Urology News)
- High Prostate Cancer Risk Linked to Inherited Mutations in DNA-repair Genes (Prostate Cancer News Today)
- ‘Smart’ nanoparticle called PEARLs a promising gem to target, treat tumours (EurekAlert!)
- Technavio Announces Top Four Trends for the Global Penile Implants Market through 2020 (Business Wire)
- Study Finds evidence that PD-1 Antibody may Benefit Men with Metastatic Prostate Cancer (News Medical)
- Familial Risk of Aggressive Prostate Cancer Quantified. (Renal & Urology)
- Prostate Cancer Patients Taking Statins Lived Longer (Renal & Urology News)
- Novel Agent Being Explored in Two Trials of High-Risk Prostate Cancer (Cure Today)
- Yoga May Benefit Men Undergoing Radiation for Prostate Cancer (Cure Today)
- Presence of P. acnes In Prostate Tissue Associated With Prostate Cancer (Cancer Therapy Advisor)
- U.S. Hospital Adopts ‘Watchful Waiting’ as Standard for Low-Risk Prostate Cancers Due to MRI Advances (Prostate Cancer News Today)
- Cabozantinib Not Superior to Prednisone for Pretreated mCRPC (Cancer Therapy Advisor)
- Researchers Estimate Familial Prostate Cancer Risk (Oncology Nurse Advisor)
- Dr Loppenberg on Benefits of Local Treatment for Metastatic Prostate Cancer (Onc Live)
- Statins: Could They Decrease Death Risk in Four Major Cancers? (Medical News Today)
- Mutations Suggest New Prostate Cancer Options (Med Page Today)
- Precision Medicine Initiative Gearing Up (Med Page Today)
- Inherited Mutations Common Among Men With Metastatic Prostate Cancer (Renal & Urology News)
- Leading Researchers Recommend Major Change in Prostate Cancer Treatment (Washington Post)
- Regulatory Endpoints for Approval: ORR, OS, or PFS? (Medscape)
- Robotic Rectum to Further Prostate Cancer Research (Reuters)
- Lymphovascular Invasion Helps Predict Post-RP Biochemical Recurrence (Renal and Urology News)
- Salmonella ‘Game-Changer’ Could Shrink Cancer Cells (BBC)
- Consumption of Tree Nuts Associated With Reduced Mortality for Patients With Prostate Cancer (Oncology Nurse Advisor)
- VA Plans Massive Expansion of Cancer Treatment Options (Military Times)
- Prostate Cancer: New Directions With Active Surveillance (Med Page Today)
- Prostate Cancer: Driving the Personalized Medicine Highway (Med Page Today)
June 2016
- Prostate Cancer: A Patient’s Journey (Med Page Today)
- Prostate Cancer Diagnoses Decline from 2011 to 2013 (Cancer Therapy Advisor)
- Study: Racially Biased Oncologists Spend Less Time With Black Cancer Patients (Atlanta Black Star)
- Researchers Working on Non-Invasive Prostate Cancer Diagnosis Using Urine Sample (Prostate Cancer News Today)
- Liquid Biopsy Biomarkers Identify Prostate Cancer Before Surgery (Science Daily)
- Smokers Face Delayed Continence Recovery After Prostate Surgery (Renal and Urology News)
- Drug Candidate Fexapotide Reduces Rates of Prostate Cancer in Men With BPH, Study Shows (Prostate Cancer News Today)
- Visceral Fat Predicts Prostate Cancer Treatment Outcomes (Renal and Urology News)
- Testosterone Replacement Safe for Men with Prostate Cancer (Renal and Urology News)
- ADT Plus Radiotherapy Boosts Survival in Metastatic Prostate Cancer (Cancer Therapy Advisor)
- Screening Smarter With PSA Testing (Med Page Today)
- RT Improved Survival Over ADT Alone in Metastatic Prostate Cancer (Cancer Network)
- Hypofractionated RT Effective for Localized Prostate Cancer (Cancer Therapy Advisor)
- Safety, Survival Advantage of Radium-223 Continues to Offer Benefit in mCRPC (Onc Live)
- NIH Rejects Petition to Override Patent on Pricey Prostate Cancer Drug (STAT)
- Disclosure of Specialty Bias Affects Patient’s Tx Choices (Med Page Today)
- Which ADT is Smarter for the Heart? (Medscape)
- Single PSA Cut-Point May Signal Progression (Med Page Today)
- Prostate Cancer: Informed Decisions or Information Overload (Med Page Today)
- Midlife PSA Levels Predict Lethal Prostate Cancer (Renal and Urology News)
- Preventing Overtreatment of Prostate Cancer: New Model Identifies Ideal Patients for Active Surveillance (Cancer Therapy Advisor)
- Can Liquid Biopsies and Tumor Biomarkers Personalize Prostate Cancer Treatment? (Cancer Network)
- Screening PSA Levels in Younger Men Could Accurately Predict Future Risk of Prostate Cancer (News Medical)
- Alterations in Metabolic Pathways in Prostate Cancer Hint at Potential New Treatments (Oncology Nurse Advisor)
- Tasquinimod Improves rPFS for Patients with Metastatic Castration-Resistant Prostate Cancer (Cancer Therapy Advisor)
- SBRT, Proton Beam Therapy Use Increasing for Prostate CA (Medical Xpress)
- ASCO: Switch in Taxane Chemo Boosts PSA Response in mCRPC (Med Page Today)
- ASCO: No Boost in PSA Response With PARP1 Inhibitor in mCRPC (Med Page Today)
- Laser Ablation Becomes Increasingly Viable Treatment for Prostate Cancer (Science Daily)
- ASCO: Intermittent Docetaxel May be Option in mCRPC (Med Page Today)
- ASCO: Docetaxel Still King in Chemo-Naïve mCRPC Patients (Med Page Today
- Prostate Cancer Risk Strongly Influenced by Breast and Ovarian Cancer History in Family: Study (Bel Marra Health)
- Letting Go: No Reduction in Aggressive Care for Advanced Cancer (Medscape)
- ASCO: Early Markers for Survival Could Speed Up Prostate Ca Research (Med Page Today)
- Scientists Identify Biomarker for Advanced Prostate Cancer as Specific Androgen Receptor in Circulating Cancer Cells (Prostate Cancer News Today)
- In Prostate Cancer, Xtandi Sparks More Fatigue and Pain Than Zytiga (Cure Today)
- ASCO: Combo Tx Fails in Local High-Risk Prostate Ca (Med Page Today)
- ASCO: Docetaxel Falls Short in High-Risk Prostate Cancer (Med Page Today)
- ASCO: Shorter RT Course OK in Mid-Risk Prostate Cancer (Med Page Today)
- Scientists Identify Biomarker for Advanced Prostate Cancer as Specific Androgen Receptor in Circulating Cancer Cells (Prostate Cancer News Today)